Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Clinical trial NCT00446082 · COMPLETED

Trial details

NCT number: NCT00446082
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoid Tumor Acromegaly

Start date: 2006-06-01
Primary completion: 2013-11-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.